Thomasville National Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,346
Closed -$333K 202
2020
Q1
$333K Buy
+3,346
New +$385K 0.06% 156
2019
Q4
Sell
-3,346
Closed -$333K 201
2019
Q3
$333K Sell
3,346
-327
-9% -$34.2K 0.06% 156
2019
Q2
$401K Sell
3,673
-632
-15% -$67.2K 0.07% 148
2019
Q1
$481K Sell
4,305
-474
-10% -$52K 0.09% 130
2018
Q4
$461K Sell
4,779
-6,784
-59% -$720K 0.09% 130
2018
Q3
$1.41M Sell
11,563
-168
-1% -$19.8K 0.23% 77
2018
Q2
$1.29M Hold
11,731
0.22% 76
2018
Q1
$1.25M Buy
11,731
+945
+9% +$105K 0.22% 79
2017
Q4
$1.15M Buy
+10,786
New +$1.15M 0.22% 81
2015
Q2
Sell
-990
Closed -$113K 218
2015
Q1
$113K Buy
+990
New +$109K 0.04% 172

Other funds holding IBB

Thomasville National Bank's IBB Position: Q2 2020 in Review

Thomasville National Bank sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 3,346 shares — an estimated $333K sold.

Thomasville National Bank first reported a position in IBB in Q1 2015 and held it in 10 quarters. The position peaked at $1.41M in Q3 2018. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

  • Thomasville National Bank reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
  • Thomasville National Bank sold 3,346 iShares Biotechnology ETF shares in Q2 2020, an estimated $333K.
  • Thomasville National Bank first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 10 quarters.
  • Thomasville National Bank's iShares Biotechnology ETF position peaked at $1.41M in Q3 2018.
  • 766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on Thomasville National Bank's 13F filing for Q2 2020, filed 1 Jul 2020.